Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Entrada Therapeutics, Inc. (TRDA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  0.00.00.08.2
            Revenue growth    -100.0% 
Cost of goods sold  0.00.00.011.8
Gross profit  0.00.00.0-3.6
            Gross margin     -43.9%
Selling, general and administrative   [+]30.615.25.63.6
Research and development  66.635.921.1 
Other operating expenses     4.6
EBITDA   [+]-95.4-50.0-26.3-11.7
            EBITDA margin     -142.6%
Depreciation and amortization  1.91.10.30.1
EBIT   [+]-97.2-51.1-26.7-11.8
            EBIT margin     -143.9%
Other income (expense), net  2.60.00.16.7
Pre-tax income  -94.6-51.2-26.5-5.1
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -94.6-51.2-26.5-5.1
            Net margin     -62.1%
   
Basic EPS   [+]($3.02)($8.16)($24.00)($5.47)
Diluted EPS   [+]($3.02)($8.16)($24.00)($5.47)
   
Shares outstanding (basic)   [+]31.36.31.10.9
Shares outstanding (diluted)   [+]31.36.31.10.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy